Bilirubin impacts microglial lipophagy via the AMPK-mTOR signaling pathway
Neurochemistry International · 2026
DOI: 10.1016/j.neuint.2026.106266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2026. Verfasst von Shasha Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Healt…. Hauptthemen laut MEDLINE: Microglia, TOR Serine-Threonine Kinases, Autophagy, AMP-Activated Protein Kinases. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND: Hyperbilirubinemia arises from disrupted bilirubin homeostasis, which can lead to bilirubin encephalopathy (BE). Unconjugated bilirubin (UCB)-induced neuroinflammation plays a pivotal role in the pathogenesis and progression of BE. PURPOSE: To delineate the role and molecular mechanisms of lipophagy in UCB-evoked neuroinflammation. METHODS: Western blot, qPCR, immunofluorescence, ELISA, transmission electron microscopy, mCherry-EGFP-LC3 tandem fluorescent reporter, BODIPY staining, Nissl staining, and behavioral tests were employed to evaluate differences in lipophagy, LDs accumulation, neuroinflammation, and neurological function. RESULTS: UCB significantly increased PLIN2 expression and BODIPY mean fluorescence intensity, indicating excessive LDs accumulation in microglia. This was accompanied by impaired autophagic flux, as evidenced by a reduced LC3B-II/LC3B-I ratio, elevated p62/SQSTM1, and decreased mCherry-EGFP-LC3 puncta. Furthermore, the loss of colocalization between LC3 and BODIPY confirmed impaired lipophagy. The AMPK activator AICAR restored AMPK phosphorylation, suppressed mTOR activity, and reinstated autophagic flux, thereby reducing LDs accumulation. Concurrently, AICAR reduced NLRP3 and ASC levels and decreased the release of IL-6, IL-1β, and TNF-α. Moreover, compared with UCB-MCM, UCB + AICAR-MCM reduced neuronal NLRP3 and ASC levels and restored synaptic proteins synaptophysin (SYN) and HOMER1. Furthermore, these findings were corroborated in vivo, as AICAR mitigated UCB-induced neuroinflammation, attenuated neuronal synaptic injury, and improved neurological function in BE model rats. CONCLUSION: In summary, UCB-induced microglial lipophagy is a key mechanism to link UCB to pathogenic LDs accumulation and neuroinflammation in BE. Pharmacological restoration of lipophagic flux through AMPK-mTOR activation mitigates these effects, reduces neuroinflammation, and attenuates neuronal synaptic injury. Therefore, modulating microglial lipophagy might be a promising therapeutic strategy for BE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Developm…
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Liu, S., Li, L., Li, J., Li, S., Chen, J., Sun, Q., Zhang, Y., & Hua, Z. (2026). Bilirubin impacts microglial lipophagy via the AMPK-mTOR signaling pathway. Neurochemistry International. https://doi.org/10.1016/j.neuint.2026.106266
Vancouver
Liu S, Li L, Li J, Li S, Chen J, Sun Q, et al. Bilirubin impacts microglial lipophagy via the AMPK-mTOR signaling pathway. Neurochemistry International. 2026. doi:10.1016/j.neuint.2026.106266
BibTeX
@article{Liu2026,
author = {Liu, Shasha and Li, Ling and Li, Jing and Li, Siyu and Chen, Jiaqi and Sun, Qian and Zhang, Yan and Hua, Ziyu},
title = {Bilirubin impacts microglial lipophagy via the AMPK-mTOR signaling pathway},
journal = {Neurochemistry International},
year = {2026},
doi = {10.1016/j.neuint.2026.106266}
}
EUVIMED